01 At a glance
| Recruiting body | All India Institute of Medical Sciences, New Delhi |
| Job reference | 01M0PPY8D5Q14NSYXKVVKP2TPE |
| Vacancies | 1 posts |
| Qualification | |
| Location | Department of Rheumatology, All India Institute of Medical Science, New Delhi |
| Employment | Not specified |
| Applications close | 31 Aug 2026, 11:59 PM IST |
About this post
All India Institute of Medical Sciences, New Delhi has issued an official recruitment notification for Project Coordinator-II.
One Project Coordinator-II post in a Novartis funded project concerning a study of ianalumab in participants with diffuse cutaneous systemic sclerosis.
Review the verified details below and read the linked official notification for the exact eligibility, dates and application instructions.
- Qualification
- Pay
-
Rs 30,000/- per month (as per ICMR Guidelines)
- Project
-
A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis.
- Interview expenses
-
No TA/DA will be provided for appearing in interview.
- Application mode
-
Online form
Important dates
- Last date of the receipt of application31 Aug 2026
02 Vacancies
Total vacancies: 1 posts
A category-wise breakdown is not available for this post.
03 Eligibility requirements
Education
| Qualification |
Age and relaxation
| Age and cutoff | Maximum 30 years as on 31 Aug 2026 |
Experience and other rules
| Status | Not specified in the current record |
Pay and fees
| Pay | INR 30,000 per month |
| Application fee | See the official notification |
Selection process
- Shortlisting and interviewOnly shortlisted candidates will be invited for the interview.
04 How to apply
Complete every required step in sequence. A portal registration alone may not complete the application.
Follow these steps in order
- 01Application submission
Interested candidates can fill this form and submit the CV
Official application routes
Use the route specified for your apprentice or qualification group.
| Who should use it | Official URL printed in notification | Establishment ID |
|---|---|---|
| Interested candidates | https://forms.gle/4zi51chlaacYyHWY9 | — |
Before final submissionRecheck your category, qualification, marks, contact details and uploaded documents. Use only the verified official routes shown on this page.
Important official conditions
Condition
| Project | A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis. |
| Interview expenses | No TA/DA will be provided for appearing in interview. |
Reader discussion
Comments
Comments are text-only and moderated. Do not post phone numbers, document numbers or other personal information.